Keros Therapeutics
Francis Wolenski is an accomplished professional in the field of toxicology and bioanalysis, currently serving as the Executive Director of Toxicology & Bioanalysis at Keros Therapeutics. Previously, Francis held the position of Director of Toxicology at Blueprint Medicines and worked as a Toxicologist & Non-Clinical Lead at Takeda. With extensive experience in toxicology, Francis has demonstrated leadership and expertise across multiple roles in the pharmaceutical industry.
This person is not in any teams